Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector containing the human NADH dehydrogenase 4 gene

EU orphan designation number: EU/3/11/860   
Active ingredient: Adeno-associated viral vector containing the human NADH dehydrogenase 4 gene
Indication: Treatment of Leberīs hereditary optic neuropathy
Sponsor: Gensight-Biologics
89 rue du Faubourg St Antoine, 75011 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/05/2011 Centralised Orphan - Designation EMA/OD/164/10 (2011)3486 of 13/05/2011
26/09/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/164/10/T/01 (2013)6304 of 24/09/2013